NP
Nicholas P. France
Senior Vice President Of Clinical Development at Recode Therapeutics
View Nicholas's Contact Info for Free. Sign Up and Get 50 Free Contacts Per Month.Get Started for Free
Work Experience
Senior Vice President Of Clinical Development
Present
Company Details
11-50 Employees
ReCode Therapeutics is a clinical-stage genetic medicines company using superior delivery to power the next wave of mRNA and gene correction therapeutics. ReCode’s selective organ targeting (SORT) lipid nanoparticle (LNP) platform is a next-generation, genetic medicines technology that enables precise delivery to target organs and cells beyond the liver.
Year Founded
2015
Social Media
LinkedinTwitter
Industry
Biotechnology Research
HQ Location
Menlo Park, California & Dallas, Texas, US
Keywords
RNA TherapiesGenetic MedicinesNon-Viral Lipid NanoparticlesGenetic Respiratory DiseaseCystic FibrosisPrimary Ciliary DyskinesiBiotechnology
Discover More About Cleveland Clinic

Find verified contacts of Nicholas P. France in seconds from 700M people profiles. Start now!

No Credit Card Needed. By signing up, you understand and agree to Futern's Terms and Policy.